FDA Voucher Leads to Speedy Approval of Boehringer Drug for First-Line Use in Lung CancerNews DeskFebruary 26, 20260 A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature,…